Literature DB >> 1644930

Absence of hereditary p53 mutations in 10 familial leukemia pedigrees.

C A Felix1, D D'Amico, T Mitsudomi, M M Nau, F P Li, J F Fraumeni, D E Cole, J McCalla, G H Reaman, J Whang-Peng.   

Abstract

Germline p53 mutations have been identified in the Li-Fraumeni syndrome but the role of such mutations in familial leukemia is not established. The p53 gene was examined by single-strand conformation polymorphism analysis of exons 4-8 in 10 families with multiple members affected with leukemia. The diagnoses included acute and chronic leukemias and Hodgkin's disease. Identified in two families were p53 mutations that were nonhereditary. These included a 2-bp deletion in exon 6 found in the lymphoblast DNA of one child whose sibling, cousin, and several adult relatives had acute leukemia. The other nonhereditary p53 mutation was a transition at codon 248 (CGG to CAG, arginine to glutamine) found in the lymphoblasts of a patient with a preleukemic syndrome and acute lymphoblastic leukemia (ALL) whose brother is a long-term survivor of ALL. Thus, p53 mutations were found to occur in two families but both were nonhereditary. Moreover, in the remaining eight families no p53 mutation was identified in the regions of p53 where most mutations have been found in other cancers. Although p53 mutations sometimes may be present, they do not appear to be a primary event responsible for hereditary susceptibility to familial leukemia. This study suggests involvement of other genes or mechanisms.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1644930      PMCID: PMC443147          DOI: 10.1172/JCI115907

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  31 in total

1.  Chromosome preparations of bone marrow cells without prior in vitro culture or in vivo colchicine administration.

Authors:  J H TJIO; J WHANG
Journal:  Stain Technol       Date:  1962-01

2.  Nonrandom structural and numerical chromosome changes in non-small-cell lung cancer.

Authors:  J Whang-Peng; T Knutsen; A Gazdar; S M Steinberg; H Oie; I Linnoila; J Mulshine; M Nau; J D Minna
Journal:  Genes Chromosomes Cancer       Date:  1991-05       Impact factor: 5.006

3.  Hereditary and acquired p53 gene mutations in childhood acute lymphoblastic leukemia.

Authors:  C A Felix; M M Nau; T Takahashi; T Mitsudomi; I Chiba; D G Poplack; G H Reaman; D E Cole; J J Letterio; J Whang-Peng
Journal:  J Clin Invest       Date:  1992-02       Impact factor: 14.808

4.  p53 mutations in human lymphoid malignancies: association with Burkitt lymphoma and chronic lymphocytic leukemia.

Authors:  G Gaidano; P Ballerini; J Z Gong; G Inghirami; A Neri; E W Newcomb; I T Magrath; D M Knowles; R Dalla-Favera
Journal:  Proc Natl Acad Sci U S A       Date:  1991-06-15       Impact factor: 11.205

Review 5.  The p53 tumour suppressor gene.

Authors:  A J Levine; J Momand; C A Finlay
Journal:  Nature       Date:  1991-06-06       Impact factor: 49.962

6.  Mutations of the p53 gene in lymphoid leukemia.

Authors:  K Sugimoto; H Toyoshima; R Sakai; K Miyagawa; K Hagiwara; H Hirai; F Ishikawa; F Takaku
Journal:  Blood       Date:  1991-03-15       Impact factor: 22.113

7.  Second neoplasms after acute lymphoblastic leukemia in childhood.

Authors:  J P Neglia; A T Meadows; L L Robison; T H Kim; W A Newton; F B Ruymann; H N Sather; G D Hammond
Journal:  N Engl J Med       Date:  1991-11-07       Impact factor: 91.245

Review 8.  p53 mutations in human cancers.

Authors:  M Hollstein; D Sidransky; B Vogelstein; C C Harris
Journal:  Science       Date:  1991-07-05       Impact factor: 47.728

9.  Germ-line and somatic p53 gene mutations in multifocal osteogenic sarcoma.

Authors:  A Iavarone; K K Matthay; T M Steinkirchner; M A Israel
Journal:  Proc Natl Acad Sci U S A       Date:  1992-05-01       Impact factor: 11.205

10.  p53 gene mutations in non-small-cell lung cancer cell lines and their correlation with the presence of ras mutations and clinical features.

Authors:  T Mitsudomi; S M Steinberg; M M Nau; D Carbone; D D'Amico; S Bodner; H K Oie; R I Linnoila; J L Mulshine; J D Minna
Journal:  Oncogene       Date:  1992-01       Impact factor: 9.867

View more
  4 in total

1.  Anticipation in familial leukemia.

Authors:  M Horwitz; E L Goode; G P Jarvik
Journal:  Am J Hum Genet       Date:  1996-11       Impact factor: 11.025

Review 2.  Leukaemia and Sellafield: is there a heritable link?

Authors:  E J Tawn
Journal:  J Med Genet       Date:  1995-04       Impact factor: 6.318

3.  Identification of TP53 as an acute lymphocytic leukemia susceptibility gene through exome sequencing.

Authors:  Bradford C Powell; Lichun Jiang; Donna M Muzny; Lisa R Treviño; Zoann E Dreyer; Louise C Strong; David A Wheeler; Richard A Gibbs; Sharon E Plon
Journal:  Pediatr Blood Cancer       Date:  2012-12-19       Impact factor: 3.167

4.  P53 mutation in acute T cell lymphoblastic leukemia is of somatic origin and is stable during establishment of T cell acute lymphoblastic leukemia cell lines.

Authors:  J Yeargin; J Cheng; A L Yu; R Gjerset; M Bogart; M Haas
Journal:  J Clin Invest       Date:  1993-05       Impact factor: 14.808

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.